KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Merck (MRK) EBITDA (2016 - 2025)

Historic EBITDA for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $2.9 billion.

  • Merck's EBITDA rose 2880000.0% to $2.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 billion, marking a year-over-year increase of 55973.03%. This contributed to the annual value of $4.7 billion for FY2024, which is 13331.46% up from last year.
  • Merck's EBITDA amounted to $2.9 billion in Q3 2025, which was up 2880000.0% from $1.4 billion recorded in Q2 2025.
  • In the past 5 years, Merck's EBITDA ranged from a high of $2.9 billion in Q3 2025 and a low of -$9.4 billion during Q2 2023
  • Moreover, its 5-year median value for EBITDA was $35.0 million (2021), whereas its average is -$178.6 million.
  • Its EBITDA has fluctuated over the past 5 years, first tumbled by 2301666.67% in 2021, then soared by 2880000.0% in 2025.
  • Merck's EBITDA (Quarter) stood at $35.0 million in 2021, then tumbled by 1151.43% to -$368.0 million in 2022, then plummeted by 1519.02% to -$6.0 billion in 2023, then surged by 105.74% to $342.0 million in 2024, then soared by 745.03% to $2.9 billion in 2025.
  • Its last three reported values are $2.9 billion in Q3 2025, $1.4 billion for Q2 2025, and $2.5 billion during Q1 2025.